and added dropwise to a solution of cystamine dihydrochloride
(0.3 g, 1.3 mmol) in dry acetonitrile (15 mL) containing 2.0 mL of
triethylamine over 1~1.5 h in an ice bath. After 8 h, the solvent was
removed under reduced pressure and the residue was washed with
water. The purple residue was dried in a vacuum oven and purified
by column chromatography (using CH2Cl2/methanol = 20:1 as
eluent). The first pink band was collected to afford B (0.64 g,
yield: 55.6%). IR (KBr pellet, cm-1): 3078, 2969, 2928, 1693, 1614,
1515, 1229, 1118, 819, 785, 756, 699. 1H NMR (CDCl3, 400 MHz)
d (ppm): 1.17 (24H, t, J = 7.0 Hz), 2.27 (4H, q), 3.29 (4H, m),
3.35 (16H, q, J = 7.0 Hz), 6.28 (4H, d), 6.38 (4H, s), 6.45 (4H,
d), 7.07 (2H, m), 7.43 (4H, m), 7.90 (2H, m). 13C NMR (CDCl3,
100 MHz) d (ppm): 12.7, 35.9, 40.0, 44.4, 65.0, 97.9, 105.5, 108.0,
122.7, 124.0, 128.1, 128.8, 131.8, 132.4, 149.0, 153.7, 167.5. TOF-
HRMS [M]+: m/z, found 1000.4746, calcd 1000.4743.
Experimental section
Materials and methods
UV-vis absorption and fluorescence spectra were recorded in a
Hitachi U-3010 absorption spectrometer and a Hitachi F-4500 flu-
orescence spectrometer, respectively. NMR spectra were recorded
on a Bruker-400 (400 MHz). Mass spectroscopy was measured on
either a Finnigan GC-MS 4021 or a Bruker Paltonics FlexAnlysis
BA060655 MS-spectrometer instrument. Cationic compounds
such as LiClO4, NaClO4, KClO4, AgNO3, CuI, Mg(ClO4)2,
Ca(ClO4)2, Pb(ClO4)2, Fe(ClO4)2, FeCl3, CoCl2, NiCl2, Cu(ClO4)2,
Zn(ClO4)2, Cd(ClO4)2, Hg(ClO4)2 were purchased from Aldrich,
and were used as received. Rhodamine B base was analytical grade,
purchased from Beijing Chemical and recrystallized once before
use. Dry 1,2-dichloroethane and acetonitrile were distilled from
these refluxing solvents with CaH2. Ethanol for spectra detection
was HPLC reagent without fluorescent impurity and H2O was
deionized water. Flash chromatography was carried out on silica
gel 60 (200–300 mesh; Qingdao Haiyang Chemical Co., Ltd).
All experiments were carried out in an ethanol/water (v/v =
80/20) solution except when specifically described. The stock
solution of A or B was prepared in ethanol/CH2Cl2 (v/v =
8/2) (1.0 ¥ 10-3 M), stored at -25 ◦C and thawed in the dark
before use. The cationic solutions were prepared in ethanol/water
(v/v = 80/20) with concentrations of 1.0 ¥ 10-2 M for fluorescence
and UV-vis measurements. To a quartz cell (1 cm of optical
path length) filled with 2 mL of A or B was added the stock
solution of cations dropwise using a micro-syringe. The volume
of these added cationic stock solutions was less than 100 mL to
leave the concentration of A or B unchanged. All fluorescence
Compound A. Compound B (100 mg, 0.1 mmol) was dissolved
in 10 mL of CHCl3 and added to a mixture of P4S10 (32 mg,
0.07 mmol) and HMDO (0.2 mL, 0.94 mmol) in 10 mL of
CHCl3. The reaction mixture was refluxed for 4 hours under a N2
atmosphere. After the removal of CHCl3, the residue was purified
by chromatography (CH2Cl2/petroleum = 4:1 as eluent) to give
A (20 mg, yield: 19%). IR (KBr pellet, cm-1): 2968, 2967, 1615,
1516, 1397, 1220, 1118, 818, 770. 1H NMR (CDCl3, 400 MHz) d
(ppm): 1.12 (24H, t, J = 6.5 Hz), 2.39 (4H, m), 3.28 (16H, m), 3.54
(4H, m), 6.26 (12H, m), 7.09 (2H, m), 7.49 (4H, m), 8.12 (2H, m).
13C NMR (CDCl3, 100 MHz) d (ppm): 12.7, 29.8, 35.0, 44.5, 73.6,
98.1, 103.4, 108.2, 123.5, 124.9, 128.7, 132.4, 138.6, 149.3, 150.1,
153.5, 190.0. MALDI-TOF-MS found [M + H]+: m/z, 1033.462,
calcd 1033.44.
Compound C. Compound A (103 mg, 0.1 mmol) was dissolved
in CH2Cl2/ethanol (1:1, 20 mL). To the solution of A, was
added Hg(ClO4)2·3H2O (227 mg, 0.5 mmol). After stirring for
10 min, the solvent was removed under reduced pressure and
the residue was purified by column chromatography (using ethyl
acetate/ethanol = 3/1 as eluent). The red band was collected and
the solvent was removed under vacuum to afford C (15.6 mg, yield:
16.1%). IR (KBr pellet, cm-1): 2970, 2926, 1589, 1412, 1338, 1181,
1074, 822, 683. 1H NMR (CDCl3, 400 MHz) d (ppm): 1.33 (12H,
t, J = 7.12 Hz), 3.21 (2H, t, J = 8.4 Hz), 3.63 (8H, q, J = 7.16 Hz),
4.00 (2H, t, J= 8.4), 6.80 (2H, m), 6.89 (2H, d), 7.14 (2H, d), 7.27
(1H, m), 7.68 (2H, m), 7.95 (1H, m). 13C NMR (CDCl3, 100 MHz)
d (ppm): 12.8, 34.6, 46.2, 65.5, 96.79, 113.7, 113.9, 130.3, 130.5,
130.7, 130.9, 131.6, 133.4, 155.5, 157.8 166.3. ESI-HRMS [M]+:
m/z, 484.2433 found, calcd 484.2417.
◦
spectra were recorded at 25 C under excitation of 510 nm. The
maximum fluorescence intensities at 580 nm were analyzed against
the concentrations of added cations.
Cell culture
HK-2 cells (gifted from the center of cells, Peking Union Medical
College) were cultured in culture media (DMEM/F12 supple-
mented with 10% FBS, 50 unit/mL penicillin, and 50 mg/mL of
streptomycin) at 37 ◦C in a humidified incubator. HK-2 cells were
seeded in a 6-well plate at a density of 104 cells per well in culture
media. After 24 h, the cells were incubated with 10 mM of A in
culture media for 20–30 min at 37 ◦C. After carefully washing
with PBS to remove free A, the cells pretreated with A were then
incubated with HgCl2 in different concentrations in culture media
for another 30 min at 37 ◦C. These cells were imaged using confocal
fluorescence microscopy (excitation light source: Green; Olympus
IX 71 S 8F-2).
Acknowledgements
This work was supported by NNSF of China (No.20673132), the
Croucher Foundation of Hong Kong, the Chinese Academy of
Sciences “hundred talents program”, the National Basic Research
Program of China (No. 2006CB933000) and the 111 Project
(B07012).
Synthesis
Compound B. To a solution of rhodamine B base (1.0 g,
2.3 mmol) in 1,2-dichloroethane (15 mL), was added phosphorus
oxychloride (0.75 mL, 8.2 mmol) dropwise over 5 min under
stirring. The mixture solution was refluxed for 4 hours. After the
reaction mixture was cooled down to r.t., the solvent was removed
under reduced pressure to obtain rhodamine B acyl chloride,
which was directly used in the next step. The crude rhodamine
B acyl chloride (2.3 mmol) was dissolved in acetonitrile (30 mL)
Notes and references
1 L. Patrick, Altern. Med. Rev., 2002, 7, 456.
2 US EPA, Regulatory Impact Analysis of the Clean Air Mercury Rule:
Final Report. EPA-452/R-05–003, Research Triangle Park, NC, 2005.
3 T. W. Clarkson and L. Magos, Crit. Rev. Toxicol., 2006, 36, 609.
This journal is
The Royal Society of Chemistry 2009
Org. Biomol. Chem., 2009, 7, 660–664 | 663
©